A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pentoxifylline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Domperidone.
Pentoxifylline
Safinamide
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Safinamide is combined with Domperidone.
Pentoxifylline
Nialamide
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Nialamide is combined with Domperidone.
Pentoxifylline
Iproniazid
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Iproniazid is combined with Domperidone.
Pentoxifylline
Clorgiline
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Clorgiline is combined with Domperidone.
Pentoxifylline
Pargyline
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Pargyline is combined with Domperidone.
Pentoxifylline
Rasagiline
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Rasagiline is combined with Domperidone.
Pentoxifylline
Isocarboxazid
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Isocarboxazid is combined with Domperidone.
Pentoxifylline
Moclobemide
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Moclobemide is combined with Domperidone.
Pentoxifylline
Procarbazine
The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Procarbazine is combined with Domperidone.
Pentoxifylline
Teriflunomide
The serum concentration of Domperidone can be decreased when it is combined with Teriflunomide.
Pentoxifylline
Deferasirox
The serum concentration of Domperidone can be increased when it is combined with Deferasirox.
Minaprine
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Naloxone.
Minaprine
Oliceridine
The serum concentration of Oliceridine can be increased when it is combined with Naloxone.
Minaprine
Lurbinectedin
The serum concentration of Lurbinectedin can be increased when it is combined with Naloxone.
Minaprine
Ripretinib
The serum concentration of Ripretinib can be increased when it is combined with Naloxone.
Minaprine
Pemigatinib
The metabolism of Pemigatinib can be decreased when combined with Naloxone.
Minaprine
Selumetinib
The serum concentration of Selumetinib can be increased when it is combined with Naloxone.
Minaprine
Neratinib
The serum concentration of Neratinib can be increased when it is combined with Naloxone.
Minaprine
Osilodrostat
The serum concentration of Osilodrostat can be increased when it is combined with Naloxone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3